Honma Y - Search Results

1

Hepatocyte Growth Factor and Primary Systemic Amyloidosis.

Karasuyama T, Honma Y, Kumamoto K, Shibata M, Watanabe T, Shimajiri S, Abe S, Yamashita T, Harada M. Karasuyama T, et al. Among authors: honma y. J UOEH. 2021;43(2):227-233. doi: 10.7888/juoeh.43.227. J UOEH. 2021. PMID: 34092767 Free article.

2

Late diagnosed Wilson disease with hepatic and neurological manifestations.

Honma Y, Harada M, Sato M, Katsuki Y, Hiura M, Shibata M, Narita R, Harada R, Abe S, Tabaru A, Tajiri N, Shimajiri S. Honma Y, et al. Hepatol Res. 2011 Mar;41(3):270-6. doi: 10.1111/j.1872-034X.2010.00754.x. Hepatol Res. 2011. PMID: 21338455

3

Rapid progression of hepatocellular carcinoma in a patient with autoimmune hepatitis.

Yamamoto K, Hiura M, Tabaru A, Honma Y, Narita R, Abe S, Shimajiri S, Okamoto K, Yamaguchi K, Harada M. Yamamoto K, et al. Among authors: honma y. Intern Med. 2011;50(13):1409-13. doi: 10.2169/internalmedicine.50.4873. Epub 2011 Jul 1. Intern Med. 2011. PMID: 21720061 Free article.

4

Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction.

Harada M, Miyagawa K, Honma Y, Hiura M, Shibata M, Matsuhashi T, Abe S, Harada R, Tabaru A. Harada M, et al. Among authors: honma y. Intern Med. 2011;50(14):1461-4. doi: 10.2169/internalmedicine.50.5209. Epub 2011 Jul 15. Intern Med. 2011. PMID: 21757830 Free article.

5

Sorafenib enhances proteasome inhibitor-induced cell death via inactivation of Akt and stress-activated protein kinases.

Honma Y, Shimizu S, Takehara T, Harada M. Honma Y, et al. J Gastroenterol. 2014 Mar;49(3):517-26. doi: 10.1007/s00535-013-0796-z. Epub 2013 Mar 31. J Gastroenterol. 2014. PMID: 23543326

6

Sorafenib enhances proteasome inhibitor-mediated cytotoxicity via inhibition of unfolded protein response and keratin phosphorylation.

Honma Y, Harada M. Honma Y, et al. Exp Cell Res. 2013 Aug 15;319(14):2166-78. doi: 10.1016/j.yexcr.2013.05.023. Epub 2013 May 31. Exp Cell Res. 2013. PMID: 23727131

7

New therapeutic strategy for hepatocellular carcinoma by molecular targeting agents via inhibition of cellular stress defense mechanisms.

Honma Y, Harada M. Honma Y, et al. J UOEH. 2014 Dec 1;36(4):229-35. doi: 10.7888/juoeh.36.229. J UOEH. 2014. PMID: 25501753 Free article. Review.

8

Alleviation mechanisms against hepatocyte oxidative stress in patients with chronic hepatic disorders.

Hiura M, Honma Y, Miyagawa K, Oe S, Shimajiri S, Mihara H, Oe M, Sato-Morita M, Katsuki Y, Harada M. Hiura M, et al. Among authors: honma y. Hepatol Res. 2015 Nov;45(11):1124-35. doi: 10.1111/hepr.12478. Epub 2015 Mar 3. Hepatol Res. 2015. PMID: 25581125

9

Hepatitis A complicated with acute renal failure and high hepatocyte growth factor: A case report.

Oe S, Shibata M, Miyagawa K, Honma Y, Hiura M, Abe S, Harada M. Oe S, et al. Among authors: honma y. World J Gastroenterol. 2015 Aug 28;21(32):9671-4. doi: 10.3748/wjg.v21.i32.9671. World J Gastroenterol. 2015. PMID: 26327776 Free PMC article.

10

Lipid-Induced Endoplasmic Reticulum Stress Impairs Selective Autophagy at the Step of Autophagosome-Lysosome Fusion in Hepatocytes.

Miyagawa K, Oe S, Honma Y, Izumi H, Baba R, Harada M. Miyagawa K, et al. Among authors: honma y. Am J Pathol. 2016 Jul;186(7):1861-1873. doi: 10.1016/j.ajpath.2016.03.003. Epub 2016 May 6. Am J Pathol. 2016. PMID: 27157992 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

884 results

Search Page

Filters